Cargando…

Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids

The human colon is home to more than a trillion microorganisms that modulate diverse gastrointestinal processes and pathophysiologies. Our understanding of how this gut ecosystem impacts human health, although evolving, is still in its nascent stages and has been slowed by the lack of accessible and...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina, Scott, Miller, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418553/
https://www.ncbi.nlm.nih.gov/pubmed/37577510
http://dx.doi.org/10.21203/rs.3.rs-3164407/v1
_version_ 1785088291856449536
author Medina, Scott
Miller, Michael
author_facet Medina, Scott
Miller, Michael
author_sort Medina, Scott
collection PubMed
description The human colon is home to more than a trillion microorganisms that modulate diverse gastrointestinal processes and pathophysiologies. Our understanding of how this gut ecosystem impacts human health, although evolving, is still in its nascent stages and has been slowed by the lack of accessible and scalable tools suitable to studying complex host-mucus-microbe interactions. In this work, we report a synthetic gel-like material capable of recapitulating the varied structural, mechanical, and biochemical profiles of native human colonic mucus to develop compositionally simple microbiome screening platforms with broad utility in microbiology and drug discovery. The viscous fibrillar material is realized through the templated assembly of a fluorine-rich amino acid at liquid-liquid phase separated interfaces. The fluorine-assisted mucus surrogate (FAMS) can be decorated with various mucins to serve as a habitat for microbial colonization and be integrated with human colorectal epithelial cells to generate multicellular artificial mucosae, which we refer to as a microbiome organoid. Notably, FAMS are made with inexpensive and commercially available materials, and can be generated using simple protocols and standard laboratory hardware. As a result, this platform can be broadly incorporated into various laboratory settings to advance our understanding of probiotic biology and inform in vivo approaches. If implemented into high throughput screening approaches, FAMS may represent a valuable tool in drug discovery to study compound metabolism and gut permeability, with an exemplary demonstration of this utility presented here.
format Online
Article
Text
id pubmed-10418553
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Journal Experts
record_format MEDLINE/PubMed
spelling pubmed-104185532023-08-12 Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids Medina, Scott Miller, Michael Res Sq Article The human colon is home to more than a trillion microorganisms that modulate diverse gastrointestinal processes and pathophysiologies. Our understanding of how this gut ecosystem impacts human health, although evolving, is still in its nascent stages and has been slowed by the lack of accessible and scalable tools suitable to studying complex host-mucus-microbe interactions. In this work, we report a synthetic gel-like material capable of recapitulating the varied structural, mechanical, and biochemical profiles of native human colonic mucus to develop compositionally simple microbiome screening platforms with broad utility in microbiology and drug discovery. The viscous fibrillar material is realized through the templated assembly of a fluorine-rich amino acid at liquid-liquid phase separated interfaces. The fluorine-assisted mucus surrogate (FAMS) can be decorated with various mucins to serve as a habitat for microbial colonization and be integrated with human colorectal epithelial cells to generate multicellular artificial mucosae, which we refer to as a microbiome organoid. Notably, FAMS are made with inexpensive and commercially available materials, and can be generated using simple protocols and standard laboratory hardware. As a result, this platform can be broadly incorporated into various laboratory settings to advance our understanding of probiotic biology and inform in vivo approaches. If implemented into high throughput screening approaches, FAMS may represent a valuable tool in drug discovery to study compound metabolism and gut permeability, with an exemplary demonstration of this utility presented here. American Journal Experts 2023-08-03 /pmc/articles/PMC10418553/ /pubmed/37577510 http://dx.doi.org/10.21203/rs.3.rs-3164407/v1 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/) , which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.
spellingShingle Article
Medina, Scott
Miller, Michael
Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title_full Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title_fullStr Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title_full_unstemmed Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title_short Synthetic Colonic Mucus Enables the Development of Modular Microbiome Organoids
title_sort synthetic colonic mucus enables the development of modular microbiome organoids
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418553/
https://www.ncbi.nlm.nih.gov/pubmed/37577510
http://dx.doi.org/10.21203/rs.3.rs-3164407/v1
work_keys_str_mv AT medinascott syntheticcolonicmucusenablesthedevelopmentofmodularmicrobiomeorganoids
AT millermichael syntheticcolonicmucusenablesthedevelopmentofmodularmicrobiomeorganoids